Long-term changes in serum gastrin levels during standard dose vonoprazan therapy.
Satoshi ShinozakiHiroyuki OsawaYoshimasa MiuraYoshikazu HayashiHirotsugu SakamotoTomonori YanoAlan Kawarai LeforHironori YamamotoPublished in: Scandinavian journal of gastroenterology (2022)
A continued increase in gastrin levels was not found during long-term vonoprazan therapy. Severe gastric atrophy is a significant risk factor for hypergastrinemia.